デフォルト表紙
市場調査レポート
商品コード
1694954

サンガーシーケンスの世界市場レポート 2025年

Sanger Sequencing Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
サンガーシーケンスの世界市場レポート 2025年
出版日: 2025年03月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

サンガーシーケンス市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率(CAGR)は16.9%で61億7,000万米ドルに成長します。予測期間の成長は、臨床ゲノミクス統合の増加、農業ゲノミクスの拡大、薬剤安全性と薬理ゲノミクスの増加、出生前および新生児スクリーニングの増加、環境DNA分析の増加に起因すると考えられます。予測期間の主な動向には、技術の進歩、次世代シーケンシングの需要拡大、臨床診断への応用拡大、ゲノミクス研究への投資増加、個別化医療での利用拡大などがあります。

遺伝性疾患の増加は、今後数年間のサンガーシーケンス市場の成長を牽引すると予想されます。遺伝性疾患(遺伝性障害)とは、遺伝情報を伝える遺伝物質である個人のDNAの異常や変異によって引き起こされる病状です。サンガーシーケンスは、特定の遺伝子やDNA領域のヌクレオチド(DNAの構成要素)の正確な順序を決定することによって、これらの疾患を診断するために使用される方法です。例えば、2024年8月、英国の公的医療機関であるナショナル・ヘルスケア・サービス(National Health Service)は、英国では約2,300人がサラセミアに罹患しており、そのうち約800人が定期的な輸血に頼る重症型であると報告しました。このように、遺伝性疾患の増加がサンガーシーケンス市場の成長に拍車をかけています。

サンガーシーケンス市場の主要企業は、英国北部で迅速なサンガーシーケンスサービスを提供するため、ゲノム研究所の拡大に注力しています。ゲノム研究所は、診断、研究、個別化医療などの目的で遺伝子やゲノムの構造、機能、遺伝を研究することを目的とした、遺伝子検査や分析を行うための専門施設です。例えば、2023年6月、英国を拠点とするゲノム・サービスのプロバイダーであるソース・ジェノミクス社は、ゲノム研究所の英国北部への拡張を発表しました。この地理的拡大は、英国全土でゲノムサービスへの公平なアクセスを提供するための重要なステップであり、全国の研究機関がより迅速な納期で高品質のサンガーシーケンスサービスの恩恵を受けることができるようになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界サンガーシーケンス PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界のサンガーシーケンス市場:成長率分析
  • 世界のサンガーシーケンス市場の実績:規模と成長, 2019-2024
  • 世界のサンガーシーケンス市場の予測:規模と成長, 2024-2029, 2034F
  • 世界サンガーシーケンス総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のサンガーシーケンス市場シーケンスによる、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ショットガンシーケンス
  • 標的遺伝子配列決定
  • その他のシーケンス
  • 世界のサンガーシーケンス市場研究室別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ウェットラボ
  • ドライラボ
  • 世界のサンガーシーケンス市場調査による、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 社内
  • アウトソーシング
  • 世界のサンガーシーケンス市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 診断
  • バイオマーカーとがん
  • 生殖に関する健康
  • パーソナライズ医療
  • 法医学
  • その他の用途
  • 世界のサンガーシーケンス市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • アカデミック
  • 政府調査機関
  • 製薬会社
  • バイオテクノロジー企業
  • 病院
  • クリニック
  • 世界のサンガーシーケンス市場、ショットガンシーケンスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 全ゲノムショットガンシーケンス
  • メタゲノムショットガンシーケンシング
  • 世界のサンガーシーケンス市場、標的遺伝子配列のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • アンプリコンシークエンシング
  • エクソームシークエンシング
  • 世界のサンガーシーケンス市場、その他のシーケンスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ネストPCRシーケンシング
  • シーケンシングバイシンセシス(SBS)

第7章 地域別・国別分析

  • 世界のサンガーシーケンス市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のサンガーシーケンス市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • サンガーシーケンス市場:競合情勢
  • サンガーシーケンス市場:企業プロファイル
    • Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Beckman Coulter
  • PerkinElmer Inc.
  • BGI Group
  • LGC Limited
  • GenScript
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • Macrogen Inc.
  • GENEWIZ Inc.
  • Quintara Biosciences
  • CeMIA SA
  • Source BioScience
  • Microsynth AG
  • Fasteris SA
  • GenHunter Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • サンガーシーケンス市場2029:新たな機会を提供する国
  • サンガーシーケンス市場2029:新たな機会を提供するセグメント
  • サンガーシーケンス市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r28931

Sanger sequencing, also known as chain termination sequencing, is a technique utilized to determine the nucleotide sequence of DNA. It finds application in smaller-scale projects and validating the results of deep sequencing, producing DNA sequence reads exceeding 500 nucleotides while maintaining high accuracy levels.

Sanger sequencing encompasses several types, including shotgun sequencing, targeted gene sequencing, and others. In shotgun sequencing, random fragments of a lengthy DNA molecule are sequenced in parallel and then pieced together using their overlapping segments. Laboratories employing Sanger sequencing methods can be categorized as wet labs or dry labs, while research endeavors can be conducted in-house or outsourced. These techniques are employed across various applications such as diagnostics, biomarkers, cancer research, reproductive health, personalized medicine, forensics, among others. Moreover, Sanger sequencing serves a diverse range of end-users including academic institutions, government research institutes, pharmaceutical companies, biotechnology firms, hospitals, and clinics.

The sanger sequencing market research report is one of a series of new reports from The Business Research Company that provides sanger sequencing market statistics, including sanger sequencing industry global market size, regional shares, competitors with a sanger sequencing market share, detailed sanger sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the sanger sequencing industry. This sanger sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.75 billion in 2024 to $3.3 billion in 2025 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to increased research demand, increasing medical diagnostics, increased pharmaceutical development, increased agricultural applications, increased forensic analysis, increased biomarker discovery, increased genetic evolution studies.

The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $6.17 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to increasing clinical genomics integration, expanded agricultural genomics, increasing drug safety and pharmacogenomics, increasing prenatal and newborn screening, increasing environmental DNA analysis. Major trends in the forecast period include technological advancements, growing demand for next-generation sequencing, increasing applications in clinical diagnostics, rising investments in genomics research, expanding use in personalized medicine.

The increase in genetic illnesses is expected to drive the growth of the Sanger sequencing market in the coming years. Genetic illnesses, or genetic disorders, are medical conditions caused by abnormalities or mutations in an individual's DNA, the hereditary material that carries genetic information. Sanger sequencing is a method used to diagnose these disorders by determining the precise order of nucleotides (the building blocks of DNA) in a specific gene or DNA region. For example, in August 2024, the National Health Service, a UK-based publicly funded healthcare organization, reported that around 2,300 people in the UK are living with thalassemia, with approximately 800 individuals affected by the severe form of the condition who rely on regular blood transfusions. Thus, the rise in genetic illnesses is fueling the growth of the Sanger sequencing market.

Leading companies in the Sanger sequencing market are focusing on expanding genomic laboratories to offer rapid Sanger sequencing services in the northern UK. Genomic laboratories are specialized facilities for conducting genetic testing and analysis, aimed at studying the structure, function, and inheritance of genes and genomes for purposes such as diagnosis, research, and personalized medicine. In June 2023, for instance, Source Genomics, a UK-based provider of genomic services, announced the expansion of their genomic laboratory to the north of the UK, which will increase their capacity for Sanger sequencing services and reduce data turnaround times. This geographic expansion represents a significant step in providing equitable access to genomic services across the UK, enabling research organizations nationwide to benefit from high-quality Sanger sequencing services with faster turnaround times.

In January 2023, Qiagen, a German company specializing in sample and assay technologies, acquired Verogen for $150 million. This strategic move enables Qiagen to optimize its renowned sample extraction and library preparation automation capabilities, thereby bolstering the channel reach and market presence of both companies in support of the forensic market. Verogen, based in the United States, is a leading provider of Sanger sequencing solutions tailored for human identification and forensic laboratories.

Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sanger sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sanger sequencing market includes revenues earned by entities by providing DNA synthesis, and targeted synthesis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sanger Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sanger sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sanger sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sanger sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Sequencing: Shotgun Sequencing; Targeted Gene Sequencing; Other Sequencing
  • 2) By Laboratory: Wet Labs; Dry Labs
  • 3) By Research: In-House; Outsourced
  • 4) By Application: Diagnostics; Biomarkers and Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
  • 5) By End User: Academic; Government Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Hospitals; Clinics
  • Subsegments:
  • 1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing; Metagenomic Shotgun Sequencing
  • 2) By Targeted Gene Sequencing: Amplicon Sequencing; Exome Sequencing
  • 3) By Other Sequencing: Nested PCR Sequencing; Sequencing By Synthesis (SBS)
  • Companies Mentioned: Hoffmann-La Roche; Thermo Fisher Scientific Inc.; Merck KGaA; Eurofins Scientific; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sanger Sequencing Market Characteristics

3. Sanger Sequencing Market Trends And Strategies

4. Sanger Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Sanger Sequencing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sanger Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sanger Sequencing Market Growth Rate Analysis
  • 5.4. Global Sanger Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sanger Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sanger Sequencing Total Addressable Market (TAM)

6. Sanger Sequencing Market Segmentation

  • 6.1. Global Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • Other Sequencing
  • 6.2. Global Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wet Labs
  • Dry Labs
  • 6.3. Global Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In-House
  • Outsourced
  • 6.4. Global Sanger Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other Applications
  • 6.5. Global Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic
  • Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals
  • Clinics
  • 6.6. Global Sanger Sequencing Market, Sub-Segmentation Of Shotgun Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Whole Genome Shotgun Sequencing
  • Metagenomic Shotgun Sequencing
  • 6.7. Global Sanger Sequencing Market, Sub-Segmentation Of Targeted Gene Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amplicon Sequencing
  • Exome Sequencing
  • 6.8. Global Sanger Sequencing Market, Sub-Segmentation Of Other Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nested PCR Sequencing
  • Sequencing By Synthesis (SBS)

7. Sanger Sequencing Market Regional And Country Analysis

  • 7.1. Global Sanger Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sanger Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sanger Sequencing Market

  • 8.1. Asia-Pacific Sanger Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sanger Sequencing Market

  • 9.1. China Sanger Sequencing Market Overview
  • 9.2. China Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sanger Sequencing Market

  • 10.1. India Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sanger Sequencing Market

  • 11.1. Japan Sanger Sequencing Market Overview
  • 11.2. Japan Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sanger Sequencing Market

  • 12.1. Australia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sanger Sequencing Market

  • 13.1. Indonesia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sanger Sequencing Market

  • 14.1. South Korea Sanger Sequencing Market Overview
  • 14.2. South Korea Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sanger Sequencing Market

  • 15.1. Western Europe Sanger Sequencing Market Overview
  • 15.2. Western Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sanger Sequencing Market

  • 16.1. UK Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sanger Sequencing Market

  • 17.1. Germany Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sanger Sequencing Market

  • 18.1. France Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sanger Sequencing Market

  • 19.1. Italy Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sanger Sequencing Market

  • 20.1. Spain Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sanger Sequencing Market

  • 21.1. Eastern Europe Sanger Sequencing Market Overview
  • 21.2. Eastern Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sanger Sequencing Market

  • 22.1. Russia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sanger Sequencing Market

  • 23.1. North America Sanger Sequencing Market Overview
  • 23.2. North America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sanger Sequencing Market

  • 24.1. USA Sanger Sequencing Market Overview
  • 24.2. USA Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sanger Sequencing Market

  • 25.1. Canada Sanger Sequencing Market Overview
  • 25.2. Canada Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sanger Sequencing Market

  • 26.1. South America Sanger Sequencing Market Overview
  • 26.2. South America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sanger Sequencing Market

  • 27.1. Brazil Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sanger Sequencing Market

  • 28.1. Middle East Sanger Sequencing Market Overview
  • 28.2. Middle East Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sanger Sequencing Market

  • 29.1. Africa Sanger Sequencing Market Overview
  • 29.2. Africa Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sanger Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Sanger Sequencing Market Competitive Landscape
  • 30.2. Sanger Sequencing Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Sanger Sequencing Market Other Major And Innovative Companies

  • 31.1. Beckman Coulter
  • 31.2. PerkinElmer Inc.
  • 31.3. BGI Group
  • 31.4. LGC Limited
  • 31.5. GenScript
  • 31.6. Oxford Nanopore Technologies
  • 31.7. Pacific Biosciences of California Inc.
  • 31.8. Macrogen Inc.
  • 31.9. GENEWIZ Inc.
  • 31.10. Quintara Biosciences
  • 31.11. CeMIA SA
  • 31.12. Source BioScience
  • 31.13. Microsynth AG
  • 31.14. Fasteris SA
  • 31.15. GenHunter Corporation

32. Global Sanger Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sanger Sequencing Market

34. Recent Developments In The Sanger Sequencing Market

35. Sanger Sequencing Market High Potential Countries, Segments and Strategies

  • 35.1 Sanger Sequencing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sanger Sequencing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sanger Sequencing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer